The FDA has granted accelerated approval to Otsuka’s Voyxact for adults with primary IgAN at risk of disease progression, ...

An international team of investigators has reported results from the first Phase III clinical trials of rocatinlimab, a novel ...

Gan & Lee Pharmaceuticals begins GRADUAL-3 phase 3 study of first Chinese once-monthly GLP-1 RA for weight management: Beijing, China Monday, December 1, 2025, 18:00 Hrs [IST] Gan ...

Alto Neuroscience, Inc.'s innovative approach to CNS disorder treatment and 2026 clinical milestones. Click here to find out why ANRO stock is a Buy.

New research has charted the major developmental stages in the brain’s wiring—from early-life pruning to late-life network ...

Children with avoidant/restrictive food intake were significantly more likely than control individuals to have developmental ...

A new study highlights how important uninterrupted sleep is to recovery after a traumatic brain injury, finding that ...

A homegrown breast cancer therapy has shown promising efficacy and safety in a clinical trial announced on Wednesday by ...

Investing.com -- Jasper Therapeutics Inc (NASDAQ:JSPR) stock surged 17.4% in premarket trading Tuesday after the clinical-stage biotech company reported positive preliminary data from its ETESIAN ...

Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in a global Phase 3 trial for Stargardt ...

One fast-rising biotech is gearing up for pivotal trials just as a major specialist fund walks away—here’s what long-term ...

Learn more about whether Immunocore Holdings plc or Viridian Therapeutics, Inc. is a better investment based on AAII's A+ ...